Caligan Partners LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$479.2B
Holdings
16
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 8,118,592 | $119.7B | 24.99% | |
| 2 | VRNAVERONA PHARMA PLC | 1,436,878 | $91.2B | 19.04% | |
| 3 | EX9EXELIXIS INC | 1,525,730 | $56.3B | 11.75% | |
| 4 | MLYSMINERALYS THERAPEUTICS INC | 2,149,667 | $34.1B | 7.12% | |
| 5 | EOLSEVOLUS INC | 2,731,154 | $32.9B | 6.86% | |
| 6 | SG7SAGE THERAPEUTICS INC | 3,052,538 | $24.3B | 5.06% | |
| 7 | BCRXBIOCRYST PHARMACEUTICALS INC | 3,107,669 | $23.3B | 4.86% | |
| 8 | ANIKANIKA THERAPEUTICS INC | 1,435,130 | $21.6B | 4.50% | |
| 9 | AGIOAGIOS PHARMACEUTICALS INC | 701,280 | $20.5B | 4.29% | |
| 10 | RVMDREVOLUTION MEDICINES INC | 465,000 | $16.4B | 3.43% | |
| 11 | MRUSMERUS N V | 376,954 | $15.9B | 3.31% | |
| 12 | YMABUSDY-MABS THERAPEUTICS INC | 2,342,609 | $10.4B | 2.17% | |
| 13 | ABVXABIVAX SA | 1,269,119 | $7.9B | 1.66% | |
| 14 | VRCAVERRICA PHARMACEUTICALS INC | 8,992,954 | $4.0B | 0.83% | |
| 15 | RZLTREZOLUTE INC | 141,309 | $409.8M | 0.09% | |
| 16 | TYRATYRA BIOSCIENCES INC | 25,000 | $232.5M | 0.05% |